NEW YORK (GenomeWeb) – The National Institutes of Health announced last week it will award $8 million to study the molecular interactions between pathogens and hosts that are associated with antibacterial-resistant infection.
The National Institute of Allergy and Infectious Diseases will commit $8 million in Fiscal Year 2016 to fund up to five awards. Total costs of up to $2 million per year may be requested, with a maximum project period of five years.
Applications are expected to take a systems biology approach to comprehensively examine molecular interaction networks to help understand the causes and effects of infectious disease, potentially aiding future antibiotic drug development. Applications are expected to use high-throughput omics and assay technologies, which may include next-generation sequencing, transcriptomics, proteomics, metabolomics, or lipidomics.
Studies of the host microbiome during antibacterial-resistant infection are also of interest, NIH said in the funding opportunity announcement, and studies using human primary cells or clinical samples from human subjects with antibacterial-resistant infections are strongly encouraged.
Applications for the grants will be accepted from June 9, 2015 to July 9, 2015.